Literature DB >> 25149598

The prognostic value of gadolinium-enhanced magnetic resonance imaging in acute invasive fungal rhinosinusitis.

Ji Heui Kim1, Byung Chul Kang1, Jung-Hyun Lee2, Yong Ju Jang1, Bong-Jae Lee1, Yoo-Sam Chung3.   

Abstract

OBJECTIVES: This study aimed to assess the prognostic value of gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) in acute invasive fungal rhinosinusitis (AIFRS) and offer recommendations for determining surgical extent based on loss of contrast enhancement (LoCE), which reveals tissue ischemia from fungal invasion.
METHODS: Preoperative and postoperative Gd-enhanced MRI was evaluated in 21 patients with confirmed AIFRS who underwent wide debridement and antifungal therapy. Patients were subdivided by AIFRS-specific survival. LoCE and contrast enhancement (CE) of intrasinonasal and extrasinonasal sites in preoperative and postoperative MRI were compared between the two groups.
RESULTS: All patients had preoperative intrasinonasal LoCE and CE lesions, which did not differ between survivors and non-survivors. Bone destruction on CT was detected in 8 of 16 survivors (50%) and 4 of 5 non-survivors (80%). Intrasinonasal LoCE lesions were completely removed by surgery in all cases. Postoperative extrasinonasal LoCE lesions were found in all non-survivors but no survivors (p < 0.001). However, postoperative intrasinonasal and extrasinonasal CE lesions were detected in both survivors and non-survivors (p = 0.119 and p = 0.111, respectively). In addition, remission of hematologic diseases at the time of diagnosis of AIFRS and blood sugar control in diabetic patients were significantly associated with AIFRS-specific survival (p = 0.028 and p = 0.023, respectively).
CONCLUSIONS: LoCE lesions, which have to be surgically removed, should be screened using Gd-enhanced MRI for an earlier diagnosis of AIFRS, determination of surgical extent, and management of follow-up. Remnant LoCE lesions after surgery, active hematologic diseases, and poorly controlled blood sugar adversely affect the AIFRS-survival.
Copyright © 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute invasive fungal rhinosinusitis; Gadolinium; Magnetic resonance imaging

Mesh:

Substances:

Year:  2014        PMID: 25149598     DOI: 10.1016/j.jinf.2014.07.027

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Acute invasive fungal rhinosinusitis: MR imaging features and their impact on prognosis.

Authors:  Ye Ra Choi; Ji-Hoon Kim; Hye Sook Min; Jae-Kyung Won; Hyun Jik Kim; Roh-Eul Yoo; Koung Mi Kang; Sun-Won Park; Tae Jin Yun; Seung Hong Choi; Chul-Ho Sohn; Jung Hyo Rhim; Soo Chin Kim; Jae Wook Ryu; Dong Gyu Na
Journal:  Neuroradiology       Date:  2018-05-17       Impact factor: 2.804

Review 2.  Diagnosis and Treatment of Acute Invasive Fungal Sinusitis in Cancer and Transplant Patients.

Authors:  Monica Fung; Jennifer Babik; Ian M Humphreys; Greg E Davis
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

Review 3.  Imaging fungal infections in children.

Authors:  Alfred O Ankrah; Mike M Sathekge; Rudi A J O Dierckx; Andor W J M Glaudemans
Journal:  Clin Transl Imaging       Date:  2016-01-25

Review 4.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08

5.  Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.

Authors:  Ruchi Goel; Ritu Arora; Shalin Shah; Mohit Chhabra; Jyoti Kumar; Nita Khurana; Swati Gupta; Samreen Khanam; Sumit Kumar; Sonam Singh; Ravi Meher; Meenakshi Thakar; Anju Garg
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-05-11       Impact factor: 2.011

6.  Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.

Authors:  Ali Sharifi; Zahra Akbari; Mohammad Shafie'ei; Naser Nasiri; Meraj Sharifi; Mohadeseh Shafiei; Amin Zand
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-08-08       Impact factor: 2.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.